Dr Lalchandani Labs
Dr Lalchandani Labs Share Price Chart
Dr Lalchandani Labs last traded at ₹6.48 (2026-10-13). Over the past month the stock moved -17.3%, three months the stock moved -30.6%, year the stock moved -66.3%. Its closing range over 52 weeks is ₹6.45 – ₹17.58, with the latest close 63.1% below the high.
Closing prices up to 2026-10-13.
About Dr Lalchandani Labs
Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations[1]
Business Overview:[1][2][3] DLLL is a NABL accredited company with 5 Self-sufficient Labs and 15 collection centers across Delhi/NCR. It is empaneled for CGHS (South, North and East Block), DJB, MCD, DDA etc. and provides diagnostic and related healthcare tests and services. Company owns, runs laboratories for carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA & Genetic Testing etc.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Dr Lalchandani Labs reported sales of ₹2.13 crore (+2.4%) and net profit of ₹-0.13 crore (-118.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2.13 | 0.13 | 6.10 | -0.13 | -0.15 |
| Sep 2025 | 2.05 | 0.26 | 12.68 | 0.20 | 0.23 |
| Mar 2025 | 2.33 | 0.51 | 21.89 | 0.27 | 0.31 |
| Sep 2024 | 2.13 | 0.54 | 25.35 | 0.15 | 0.17 |
| Mar 2024 | 2.08 | 1.04 | 50.00 | 0.71 | 0.82 |
| Sep 2023 | 2.73 | 0.35 | 12.82 | -0.09 | -0.10 |
| Mar 2023 | 2.76 | 0.26 | 9.42 | -0.59 | -0.68 |
| Sep 2022 | 2.28 | -0.18 | -7.89 | -0.97 | -1.11 |
| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -15.9% | -61.0% | -66.0% | -36.2% | -6.6% | -15.6% | -24.9% | +2.4% |
| Operating profit growth | -131.6% | -84.4% | -82.1% | +131.1% | – | +96.2% | -25.7% | -87.5% |
| Net profit growth | -521.7% | -174.7% | -108.4% | – | – | – | – | -118.3% |
| EPS growth | -526.9% | -174.7% | -108.1% | – | – | – | – | -118.3% |
| OPM % | -7.9% | 9.4% | 12.8% | 50.0% | 25.4% | 21.9% | 12.7% | 6.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Dr Lalchandani Labs reported sales of ₹4.19 crore (-5.8%) and net profit of ₹0.06 crore (-85.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.19 | 0.69 | 16.47 | 0.06 | 0.07 |
| Mar 2025 | 4.45 | 1.05 | 23.60 | 0.42 | 0.97 |
| Mar 2024 | 4.81 | 0.22 | 4.57 | 0.62 | 1.43 |
| Mar 2023 | 5.04 | 0.09 | 1.79 | -1.56 | -3.60 |
| Mar 2022 | 11.28 | 2.47 | 21.90 | 0.93 | 2.15 |
| Mar 2021 | 9.78 | 2.24 | 22.90 | 1.01 | 2.33 |
| Mar 2020 | 6.10 | 1.26 | 20.66 | 0.47 | 1.08 |
| Mar 2019 | 5.26 | 1.20 | 22.81 | 0.53 | 1.22 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +88.5% | +16.0% | +60.3% | +15.3% | -55.3% | -4.6% | -7.5% | -5.8% |
| Operating profit growth | +93.5% | +5.0% | +77.8% | +10.3% | -96.4% | +144.4% | +377.3% | -34.3% |
| Net profit growth | +103.8% | -11.3% | +114.9% | -7.9% | -267.7% | – | -32.3% | -85.7% |
| EPS growth | +37.1% | -11.5% | +115.7% | -7.7% | -267.4% | – | -32.2% | -92.8% |
| OPM % | 22.8% | 20.7% | 22.9% | 21.9% | 1.8% | 4.6% | 23.6% | 16.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Dr Lalchandani Labs.
Get Free AI Stock Analysis FREE →Latest News
-
Dr Lalchandani Labs Clarifies Non-Applicability of Large Corporate Status Under SEBI Debt Securities Circular - scanx.trade
Frequently Asked Questions
What is Dr Lalchandani Labs's current stock price?
Dr Lalchandani Labs shares were last quoted at ₹6.48 (-0.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Dr Lalchandani Labs?
Dr Lalchandani Labs has a price-to-earnings (P/E) ratio of 0.00 and a price-to-book (P/B) ratio of 0.44. The industry P/E is 99.89.
What is the 52-week high and low of Dr Lalchandani Labs?
The 52-week high of Dr Lalchandani Labs is ₹17.99 and the 52-week low is ₹5.97.
What is the market cap of Dr Lalchandani Labs?
The market capitalisation of Dr Lalchandani Labs is about ₹6.28 crore.
How did Dr Lalchandani Labs perform in its latest quarterly results?
In the latest quarter (Mar 2026), Dr Lalchandani Labs reported sales of ₹2.13 crore (+2.4%) and net profit of ₹-0.13 crore (-118.3%), compared with the same quarter last year.
Is Dr Lalchandani Labs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Dr Lalchandani Labs has a 3-year ROE of -1.00%, 3-year profit growth of 27.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Dr Lalchandani Labs?
Promoters hold about 32.90% of Dr Lalchandani Labs.
Which sector does Dr Lalchandani Labs belong to?
Dr Lalchandani Labs belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z